Cite
Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease.
MLA
Shoji, Hirotaka, et al. “Interleukin-34 as a Fibroblast-Derived Marker of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.” Scientific Reports, July 2016, p. 28814. EBSCOhost, https://doi.org/10.1038/srep28814.
APA
Shoji, H., Yoshio, S., Mano, Y., Kumagai, E., Sugiyama, M., Korenaga, M., Arai, T., Itokawa, N., Atsukawa, M., Aikata, H., Hyogo, H., Chayama, K., Ohashi, T., Ito, K., Yoneda, M., Nozaki, Y., Kawaguchi, T., Torimura, T., Abe, M., & Hiasa, Y. (2016). Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Scientific Reports, 28814. https://doi.org/10.1038/srep28814
Chicago
Shoji, Hirotaka, Sachiyo Yoshio, Yohei Mano, Erina Kumagai, Masaya Sugiyama, Masaaki Korenaga, Taeang Arai, et al. 2016. “Interleukin-34 as a Fibroblast-Derived Marker of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.” Scientific Reports, July, 28814. doi:10.1038/srep28814.